Diagnosis and treatment of nutritional deficiencies in alcoholic liver disease: Overview of available evidence and open issues

Digestive and Liver Disease

Volumn 47, Issue 10, 2015, Pages 819-825

  Rossi, Roberta Elisa ^a,b   Conte, Dario ^a,b   Massironi, Sara ^a  

^a MAGGIORE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Alcoholic liver disease; Enteral nutrition; Nutritional deficiencies; Nutritional support; Parenteral nutrition; Protein energy malnutrition

Indexed keywords

ALBUMIN; PREALBUMIN; RETINOL BINDING PROTEIN; TRACE ELEMENT; TRANSFERRIN;

ALBUMIN BLOOD LEVEL; ALCOHOL LIVER DISEASE; DIET SUPPLEMENTATION; DIET THERAPY; ENTERIC FEEDING; FOLIC ACID DEFICIENCY; HUMAN; LYMPHOCYTE COUNT; NUTRITIONAL ASSESSMENT; NUTRITIONAL DEFICIENCY; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; REVIEW; TRANSFERRIN BLOOD LEVEL; VITAMIN DEFICIENCY; COMPLICATION; LENGTH OF STAY; MALNUTRITION; NUTRITIONAL SUPPORT; SEVERITY OF ILLNESS INDEX;

ENTERAL NUTRITION; HUMANS; LENGTH OF STAY; LIVER DISEASES, ALCOHOLIC; MALNUTRITION; MICRONUTRIENTS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; SEVERITY OF ILLNESS INDEX;

EID: 84942192949     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2015.05.021     Document Type: Review

References (81)

1. Neff G.W., Duncan C.W., Schiff E.R. The current economic burden of cirrhosis. Gastroenterology & Hepatology 2011, 7:661-671.
2. Rehm J., Mathers C., Popova S., et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009, 373:2223-2233.
3. Mathurin P., Hadengue A., Bataller R., et al. European Association for the Study of Liver, EASL clinical practical guidelines: management of alcoholic liver disease. Journal of Hepatology 2012, 57:399-420.
4. Spengler E.K., Dunkelberg J., Schey R. Alcoholic hepatitis: current management. Digestive Diseases and Sciences 2014, 59:2357-2366.
5. Jaurigue M.M., Cappell M.S. Therapy for alcoholic liver disease. World Journal of Gastroenterology 2014, 20:2143-2158.
6. McClain C.J., Barve S.S., Barve A., et al. Alcoholic liver disease and malnutrition. Alcoholism, Clinical and Experimental Research 2011, 35:815-820.
7. Koretz R.L., Avenell A., Lipman T.O. Nutritional support for liver disease. Cochrane Database of Systematic Reviews 2012, 5:CD008344.
8. Singal A.K., Charlton M.R. Nutrition in alcoholic liver disease. Clinics in Liver Disease 2012, 16:805-826.
9. Caregaro L., Alberino F., Amodio P., et al. Malnutrition in alcoholic and virus related cirrhosis. American Journal of Clinical Nutrition 1996, 63:602-609.
10. Caly W.R., Strauss E., Carrilho F.J., et al. Different degrees of malnutrition and immunological alterations according to aetiology of cirrhosis: a prospective and sequential study. Nutrition Journal 2003, 2:10.
11. Purnak T., Yilmaz Y. Liver disease and malnutrition. Best Practice & Research Clinical Gastroenterology 2013, 27:619-629.
12. Plauth M., Cabre E., Riggio O., et al. ESPEN guidelines on enteral nutrition: liver disease. Clinical Nutrition 2006, 25:285-294.
13. Mendenhall C.L., Moritz T.E., Roselle G.A., et al. Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275. Journal of Parenteral and Enteral Nutrition 1995, 19:258-265.
14. Cheung K., Lee S.S., Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clinical Gastroenterology and Hepatology 2012, 10:117-125.
15. Gao B., Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011, 141:1572-1585.
16. Hughes W. Fatty liver and malignant malnutrition. Lancet 1945, 2:861.
17. Cabre E., Rodriguez-Iglesias P., Caballeria J., et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 2000, 32:36-42.
18. Foody W., Heuman D.D., Mihas A.A., et al. Nutritional therapy for alcoholic hepatitis: new life for an old idea. Gastroenterology 2001, 120:1053-1054.
19. Stickel F., Hoehn B., Schuppan D., et al. Review article: nutritional therapy in alcoholic liver disease. Alimentary Pharmacology and Therapeutics 2003, 18:357-373.
20. Manne V., Saab S. Impact of nutrition and obesity on chronic liver disease. Clinics in Liver Disease 2014, 18:205-218.
21. Teiusanu A., Andrei M., Arbanas T., et al. Nutritional status in cirrhotic patients. Maedica (Buchar) 2012, 7:284-289.
22. O'Brien A., Williams R. Nutrition in end-stage liver disease: principles and practice. Gastroenterology 2008, 134:1729-1740.
23. Medici V., Halsted C.H. Folate, alcohol, and liver disease. Molecular Nutrition & Food Research 2013, 57:596-606.
24. Herbert V., Zalusky R., Davidson C.S. Correlation of folate deficiency with alcoholism and associated macrocytosis, anemia, and liver disease. Annals of Internal Medicine 1963, 58:977-988.
25. Halsted C.H., Villanueva J., Chandler C.J., et al. Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation. Hepatology 1996, 23:497-505.
26. Halsted C.H., Villanueva J.A., Devlin A.M., et al. Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:10072-10077.
27. Chen Y.L., Yang S.S., Peng H.C., et al. Folate and vitamin B12 improved alcohol-induced hyper homocysteinemia in rats. Nutrition 2011, 27:1034-1039.
28. Esfandiari F., You M., Villanueva J.A., et al. S-adenosylmethionine attenuates hepatic lipid synthesis in micropigs fed ethanol with a folate-deficient diet. Alcoholism, Clinical and Experimental Research 2007, 31:1231-1239.
29. Vendemiale G., Altomare E., Trizio T., et al. Effects of oral S-adenosyl-l-methionine on hepatic glutathione in patients with liver disease. Scandinavian Journal of Gastroenterology 1989, 24:407-415.
30. Mato J.M., Camara J., Fernandez de Paz J., et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Journal of Hepatology 1999, 30:1081-1089.
31. Medici V., Virata M.C., Peerson J.M., et al. S-adenosyl-l-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trial. Alcoholism, Clinical and Experimental Research 2011, 35:1960-1965.
32. 12 deficiency in alcoholics. Scientific World Journal 2012, 2012:128182.
33. Lieber C.S. Relationships between nutrition, alcohol use, and liver disease. Alcohol Research and Health 2003, 27:220-231.
34. Clugston R.D., Blaner W.S. The adverse effects of alcohol on vitamin A metabolism. Nutrients 2012, 4:356-371.
35. Stickel F., Kessebohm K., Weimann R., et al. Review of liver injury associated with dietary supplements. Liver International 2011, 31:595-605.
36. Fisher L., Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clinical Gastroenterology and Hepatology 2007, 5:513-520.
37. Trépo E., Ouziel R., Pradat P., et al. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease. Journal of Hepatology 2013, 59:344-350. 10.1016/j.jhep.2013.03.024.
38. Malham M., Peter Jørgensen S., Lauridsen A.L., et al. The effect of a single oral megadose of vitamin D provided as either ergocalciferol (D2) or cholecalciferol (D3) in alcoholic liver cirrhosis. European Journal of Gastroenterology and Hepatology 2012, 24:172-178. 10.1097/MEG.0b013e32834d1755.
39. Cankutaran M., Kav T., Yavuz B., et al. Serum vitamin E levels and its relation to clinical features in nonalcoholic fatty liver disease with elevated ALT levels. Acta Gastroenterologica Belgica 2006, 69:5-11.
40. Léger D. Scurvy: reemergence of nutritional deficiencies. Canadian Family Physician 2008, 54:1403-1406.
41. Maltos A.L., Portari G.V., Saldanha J.C., et al. Scurvy in an alcoholic malnourished cirrhotic man with spontaneous bacterial peritonitis. Clinics (Sao Paulo) 2012, 67:405-407.
42. Johnson T.M., Overgard E.B., Cohen A.E., et al. Nutrition assessment and management in advanced liver disease. Nutrition in Clinical Practice 2013, 28:15-29.
43. Rodriguez-Moreno F., Gonzalez-Reimers E., Santolaria-Fernandez F., et al. Zinc, copper, manganese, and iron in chronic alcoholic liver disease. Alcohol 1997, 14:39-44.
44. McClain C.J., Antonow D.R., Cohen D.A., et al. Zinc metabolism in alcoholic liver disease. Alcoholism, Clinical and Experimental Research 1986, 10:582-589.
45. Zarski J.P., Arnaud J., Labadie H., et al. Serum and tissue concentrations of zinc after oral supplementation in chronic alcoholics with or without cirrhosis. Gastroenterologie Clinique et Biologique 1987, 11:856-860.
46. Bianchi G.P., Marchesini G., Brizi M., et al. Nutritional effects of oral zinc supplementation in cirrhosis. Nutrition Research 2000, 20:1079-1089.
47. Aargaard N.K., Andersen H., Vilstrup H., et al. Magnesium supplementation and muscle function in patients with alcoholic liver disease: a randomised placebo-controlled trial. Scandinavian Journal of Gastroenterology 2005, 40:972-979.
48. Plauth M., Cabre E., Campillo B., et al. ESPEN guidelines on parenteral nutrition: hepatology. Clinical Nutrition 2009, 28:436-444.
49. Plank L.D., Gane E.J., Peng S., et al. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomised 12-month trial. Hepatology 2008, 48:557-566.
50. Mullen K.D., Dasarathy S. Protein restriction in hepatic encephalopathy: necessary evil or illogical dogma?. Journal of Hepatology 2004, 41:147-148.
51. Cordoba J., Lopez-Hellin J., Planas M., et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. Journal of Hepatology 2004, 41:38-43.
52. Morgan T.R., Moritz T.E., Mendenhall C.L., et al. Protein consumption and hepatic encephalopathy in alcoholic hepatitis. VA Cooperative Study Group #275. Journal of the American College of Nutrition 1995, 14:152-158.
53. Plauth M., Merli M., Kondrup J., et al. ESPEN Consensus Group, ESPEN guidelines for nutrition in liver disease and transplantation. Clinical Nutrition 1997, 16:43-55.
54. Teratani T., Tomita K., Suzuki T., et al. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells. Gastroenterology 2012, 142. 152-64.e10.81.
55. Ioannou G.N., Morrow O.B., Connole M.L., et al. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. Hepatology 2009, 50:175-184.
56. Battistella F.D., Widergren J.T., Anderson J.T., et al. A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. Journal of Trauma 1997, 43:52-58.
57. Ekstedt M., Franzen L.E., Mathiesen U.L., et al. Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study. Journal of Hepatology 2007, 47:135-141.
58. Plauth M., Schuetz T., Working Group for developing the guidelines for parenteral nutrition of The German Association for Nutritional Medicine Hepatology - guidelines on parenteral nutrition, chapter 16. German Medical Science 2009, 7:Doc12.
59. Horst D., Grace N.D., Conn H.O., et al. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portalsystemic encephalopathy: a randomized controlled trial. Hepatology 1984, 4:279-287.
60. Christie M.L., Sack D.M., Pomposelli J., et al. Enriched branched-chain amino acid formula versus a casein-based supplement in the treatment of cirrhosis. Journal of Parenteral and Enteral Nutrition 1985, 9:671-678.
61. McGhee A., Henderson J.M., Millikan W.J., et al. Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients. Annals of Surgery 1983, 197:288-293.
62. Marchesini G., Bianchi G., Merli M., et al. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomised trial. Gastroenterology 2003, 124:1792-1801.
63. Muto Y., Sato S., Watanabe A., et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clinical Gastroenterology and Hepatology 2005, 3:705-713.
64. de Ledinghen V., Beau P., Mannant P.R., et al. Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices?. A randomized controlled study. Digestive Diseases and Sciences 1997, 42:536-541.
65. Baltz J.G., Argo C.K., Al-Osaimi A.M., et al. Mortality after percutaneous endoscopic gastrostomy in patients with cirrhosis: a case series. Gastrointestinal Endoscopy 2010, 72:1072-1075.
66. Calvey H., Davis M., Williams R. Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis. Journal of Hepatology 1985, 1:141-151.
67. Mendenhall C., Bongiovanni G., Goldberg S., et al. VA Cooperative Study on Alcoholic Hepatitis, III: changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy. Journal of Parenteral and Enteral Nutrition 1985, 9:590-596.
68. Mendenhall C.L., Moritz T.E., Roselle G.A., et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 1993, 17:564-576.
69. Moreno C., Langlet P., Hittelet A., et al. Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial. Journal of Hepatology 2010, 53:1117-1122.
70. Bunout D., Aicardi V., Hirsch S., et al. Nutritional support in hospitalized patients with alcoholic liver disease. European Journal of Clinical Nutrition 1989, 43:615-621.
71. Cabre E., Gonzalez-Huix F., Abad-Lacruz A., et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 1990, 98:715-720.
72. Hirsch S., Bunout D., de la Maza P., et al. Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. Journal of Parenteral and Enteral Nutrition 1993, 17:119-124.
73. Kearns P.J., Young H., Garcia G., et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992, 102:200-205.
74. Dupont B., Dao T., Joubert C., et al. Randomised clinical trial: enteral nutrition does not improve the long-term outcome of alcoholic cirrhotic patients with jaundice. Alimentary Pharmacology and Therapeutics 2012, 35:1166-1174.
75. Nasrallah S.M., Galambos J.T. Aminoacid therapy of alcoholic hepatitis. Lancet 1980, 2:1276-1277.
76. Diehl A.M., Boitnott J.K., Herlong H.F., et al. Effect of parenteral amino acid supplementation in alcoholic hepatitis. Hepatology 1985, 5:57-63.
77. Naveau S., Pelletier G., Poynard T., et al. A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients. Hepatology 1986, 6:270-274.
78. Achord J.L. A prospective randomized clinical trial of peripheral amino acid glucose supplementation in acute alcoholic hepatitis. American Journal of Gastroenterology 1987, 82:871-875.
79. Simon D., Galambos J.T. A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis. Journal of Hepatology 1988, 7:200-207.
80. Mezey E., Caballeria J., Mitchell M.C., et al. Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial. Hepatology 1991, 14:1090-1096.
81. Charlton M. Branched-chain amino acid-enriched supplements as therapy for liver disease: Rasputin lives. Gastroenterology 2003, 124:1980-1982.